Research ArticleINVITED COMMENTARIES AND SIDEBARS
Vaccine Development: Steps to Approval of an Investigational Vaccine
Emmanuel B. Walter and M. Anthony Moody
North Carolina Medical Journal March 2021, 82 (2) 141-144; DOI: https://doi.org/10.18043/ncm.82.2.141
Emmanuel B. Walter
Professor, Department of Pediatrics and chief medical officer, Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina.
M. Anthony Moody
Associate professor, Department of Pediatrics and research quality officer, Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina.

References
- 1.↵
- 2.↵
- Kanesa-thasan N,
- Shaw A,
- Stoddard JJ,
- Vernon TM.
- 3.↵
- US Food and Drug Administration
- 4.↵
- US Food and Drug Administration
- 5.↵Public Health: Immunization required, § 130A-152 (1957, 2007).
- 6.↵
- Marshall V,
- Baylor NW.
- 7.↵
- 8.↵
- Plotkin SA.
- 9.↵
- US Food and Drug Administration
- 10.↵
- 11.↵
- US Food and Drug Administration
- 12.↵
- US Department of Health & Human Services: Vaccines
In this issue
Vaccine Development: Steps to Approval of an Investigational Vaccine
Emmanuel B. Walter, M. Anthony Moody
North Carolina Medical Journal Mar 2021, 82 (2) 141-144; DOI: 10.18043/ncm.82.2.141
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.